What Directive 2010/84/EU of the European Parliament and of the Council of 19 January 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use requires
This directive establishes a robust pharmacovigilance system for medicinal products in the EU, mandating marketing authorization holders (MAHs) to monitor, report, and manage adverse drug reactions…
This is a preview. The full record adds the complete summary, 10 workflow steps, 10 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: European Medicines Agency (EMA) on behalf of the European Union · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32010L0084
SHA-256 integrity: a5f9e6922a9581a68449c44116a5554f204e051b8c5c1c796bc095ec23c489ac
Primary Citations — 5 traced to source
- Directive 2010/84/EU, Article 5 - Appointment of the Qualified Person for Pharmacovigilance
- Directive 2001/83/EC, Article 107c - Risk Management Systems and Periodic Safety Update Reports
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-pharmacovigilance-directive-2010-84-eu.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-pharmacovigilance-directive-2010-84-eu.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-pharmacovigilance-directive-2010-84-eu
- Back to registry: Browse all 10,102 compliance nodes